{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T13:26:09Z","timestamp":1793107569288,"version":"4.5.0"},"reference-count":34,"publisher":"Massachusetts Medical Society","issue":"10","license":[{"start":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T00:00:00Z","timestamp":1536192000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.nejmgroup.org\/legal\/terms-of-use.htm"}],"funder":[{"DOI":"10.13039\/501100005612","name":"Shionogi Inc., Florham Park, New Jersey, USA and Shionogi & Co., Ltd., Osaka, Japan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005612","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["N Engl J Med"],"published-print":{"date-parts":[[2018,9,6]]},"DOI":"10.1056\/nejmoa1716197","type":"journal-article","created":{"date-parts":[[2018,9,5]],"date-time":"2018-09-05T17:01:46Z","timestamp":1536166906000},"page":"913-923","source":"Crossref","is-referenced-by-count":892,"title":["Baloxavir Marboxil for Uncomplicated Influenza in Adults and Adolescents"],"prefix":"10.1056","volume":"379","author":[{"given":"Frederick G.","family":"Hayden","sequence":"first","affiliation":[{"name":"From the Department of Medicine, University of Virginia School of Medicine, Charlottesville (F.G.H.); the Department of Pediatrics, Keiyu Hospital, Yokohama (N.S.), Hirotsu Clinic, Kawasaki (N.H.), the Department of Respiratory Medicine, Kurashiki Central Hospital, Kurashiki (T.I.), Sekino Hospital, Tokyo (H.S.), Tsuchiura Beryl Clinic, Tsuchiura (K.Y.), Shionogi, Osaka (K.K., T.S., M.A., K.T., T.U.), and the Research Division for Development of Anti-Infective Agents, Institute of Development, Aging..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norio","family":"Sugaya","sequence":"additional","affiliation":[{"name":"From the Department of Medicine, University of Virginia School of Medicine, Charlottesville (F.G.H.); the Department of Pediatrics, Keiyu Hospital, Yokohama (N.S.), Hirotsu Clinic, Kawasaki (N.H.), the Department of Respiratory Medicine, Kurashiki Central Hospital, Kurashiki (T.I.), Sekino Hospital, Tokyo (H.S.), Tsuchiura Beryl Clinic, Tsuchiura (K.Y.), Shionogi, Osaka (K.K., T.S., M.A., K.T., T.U.), and the Research Division for Development of Anti-Infective Agents, Institute of Development, Aging..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuo","family":"Hirotsu","sequence":"additional","affiliation":[{"name":"From the Department of Medicine, University of Virginia School of Medicine, Charlottesville (F.G.H.); the Department of Pediatrics, Keiyu Hospital, Yokohama (N.S.), Hirotsu Clinic, Kawasaki (N.H.), the Department of Respiratory Medicine, Kurashiki Central Hospital, Kurashiki (T.I.), Sekino Hospital, Tokyo (H.S.), Tsuchiura Beryl Clinic, Tsuchiura (K.Y.), Shionogi, Osaka (K.K., T.S., M.A., K.T., T.U.), and the Research Division for Development of Anti-Infective Agents, Institute of Development, Aging..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelson","family":"Lee","sequence":"additional","affiliation":[{"name":"From the Department of Medicine, University of Virginia School of Medicine, Charlottesville (F.G.H.); the Department of Pediatrics, Keiyu Hospital, Yokohama (N.S.), Hirotsu Clinic, Kawasaki (N.H.), the Department of Respiratory Medicine, Kurashiki Central Hospital, Kurashiki (T.I.), Sekino Hospital, Tokyo (H.S.), Tsuchiura Beryl Clinic, Tsuchiura (K.Y.), Shionogi, Osaka (K.K., T.S., M.A., K.T., T.U.), and the Research Division for Development of Anti-Infective Agents, Institute of Development, Aging..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menno D.","family":"de Jong","sequence":"additional","affiliation":[{"name":"From the Department of Medicine, University of Virginia School of Medicine, Charlottesville (F.G.H.); the Department of Pediatrics, Keiyu Hospital, Yokohama (N.S.), Hirotsu Clinic, Kawasaki (N.H.), the Department of Respiratory Medicine, Kurashiki Central Hospital, Kurashiki (T.I.), Sekino Hospital, Tokyo (H.S.), Tsuchiura Beryl Clinic, Tsuchiura (K.Y.), Shionogi, Osaka (K.K., T.S., M.A., K.T., T.U.), and the Research Division for Development of Anti-Infective Agents, Institute of Development, Aging..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aeron C.","family":"Hurt","sequence":"additional","affiliation":[{"name":"From the Department of Medicine, University of Virginia School of Medicine, Charlottesville (F.G.H.); the Department of Pediatrics, Keiyu Hospital, Yokohama (N.S.), Hirotsu Clinic, Kawasaki (N.H.), the Department of Respiratory Medicine, Kurashiki Central Hospital, Kurashiki (T.I.), Sekino Hospital, Tokyo (H.S.), Tsuchiura Beryl Clinic, Tsuchiura (K.Y.), Shionogi, Osaka (K.K., T.S., M.A., K.T., T.U.), and the Research Division for Development of Anti-Infective Agents, Institute of Development, Aging..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadashi","family":"Ishida","sequence":"additional","affiliation":[{"name":"From the Department of Medicine, University of Virginia School of Medicine, Charlottesville (F.G.H.); the Department of Pediatrics, Keiyu Hospital, Yokohama (N.S.), Hirotsu Clinic, Kawasaki (N.H.), the Department of Respiratory Medicine, Kurashiki Central Hospital, Kurashiki (T.I.), Sekino Hospital, Tokyo (H.S.), Tsuchiura Beryl Clinic, Tsuchiura (K.Y.), Shionogi, Osaka (K.K., T.S., M.A., K.T., T.U.), and the Research Division for Development of Anti-Infective Agents, Institute of Development, Aging..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisakuni","family":"Sekino","sequence":"additional","affiliation":[{"name":"From the Department of Medicine, University of Virginia School of Medicine, Charlottesville (F.G.H.); the Department of Pediatrics, Keiyu Hospital, Yokohama (N.S.), Hirotsu Clinic, Kawasaki (N.H.), the Department of Respiratory Medicine, Kurashiki Central Hospital, Kurashiki (T.I.), Sekino Hospital, Tokyo (H.S.), Tsuchiura Beryl Clinic, Tsuchiura (K.Y.), Shionogi, Osaka (K.K., T.S., M.A., K.T., T.U.), and the Research Division for Development of Anti-Infective Agents, Institute of Development, Aging..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kota","family":"Yamada","sequence":"additional","affiliation":[{"name":"From the Department of Medicine, University of Virginia School of Medicine, Charlottesville (F.G.H.); the Department of Pediatrics, Keiyu Hospital, Yokohama (N.S.), Hirotsu Clinic, Kawasaki (N.H.), the Department of Respiratory Medicine, Kurashiki Central Hospital, Kurashiki (T.I.), Sekino Hospital, Tokyo (H.S.), Tsuchiura Beryl Clinic, Tsuchiura (K.Y.), Shionogi, Osaka (K.K., T.S., M.A., K.T., T.U.), and the Research Division for Development of Anti-Infective Agents, Institute of Development, Aging..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Portsmouth","sequence":"additional","affiliation":[{"name":"From the Department of Medicine, University of Virginia School of Medicine, Charlottesville (F.G.H.); the Department of Pediatrics, Keiyu Hospital, Yokohama (N.S.), Hirotsu Clinic, Kawasaki (N.H.), the Department of Respiratory Medicine, Kurashiki Central Hospital, Kurashiki (T.I.), Sekino Hospital, Tokyo (H.S.), Tsuchiura Beryl Clinic, Tsuchiura (K.Y.), Shionogi, Osaka (K.K., T.S., M.A., K.T., T.U.), and the Research Division for Development of Anti-Infective Agents, Institute of Development, Aging..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiko","family":"Kawaguchi","sequence":"additional","affiliation":[{"name":"From the Department of Medicine, University of Virginia School of Medicine, Charlottesville (F.G.H.); the Department of Pediatrics, Keiyu Hospital, Yokohama (N.S.), Hirotsu Clinic, Kawasaki (N.H.), the Department of Respiratory Medicine, Kurashiki Central Hospital, Kurashiki (T.I.), Sekino Hospital, Tokyo (H.S.), Tsuchiura Beryl Clinic, Tsuchiura (K.Y.), Shionogi, Osaka (K.K., T.S., M.A., K.T., T.U.), and the Research Division for Development of Anti-Infective Agents, Institute of Development, Aging..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takao","family":"Shishido","sequence":"additional","affiliation":[{"name":"From the Department of Medicine, University of Virginia School of Medicine, Charlottesville (F.G.H.); the Department of Pediatrics, Keiyu Hospital, Yokohama (N.S.), Hirotsu Clinic, Kawasaki (N.H.), the Department of Respiratory Medicine, Kurashiki Central Hospital, Kurashiki (T.I.), Sekino Hospital, Tokyo (H.S.), Tsuchiura Beryl Clinic, Tsuchiura (K.Y.), Shionogi, Osaka (K.K., T.S., M.A., K.T., T.U.), and the Research Division for Development of Anti-Infective Agents, Institute of Development, Aging..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatsugu","family":"Arai","sequence":"additional","affiliation":[{"name":"From the Department of Medicine, University of Virginia School of Medicine, Charlottesville (F.G.H.); the Department of Pediatrics, Keiyu Hospital, Yokohama (N.S.), Hirotsu Clinic, Kawasaki (N.H.), the Department of Respiratory Medicine, Kurashiki Central Hospital, Kurashiki (T.I.), Sekino Hospital, Tokyo (H.S.), Tsuchiura Beryl Clinic, Tsuchiura (K.Y.), Shionogi, Osaka (K.K., T.S., M.A., K.T., T.U.), and the Research Division for Development of Anti-Infective Agents, Institute of Development, Aging..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Tsuchiya","sequence":"additional","affiliation":[{"name":"From the Department of Medicine, University of Virginia School of Medicine, Charlottesville (F.G.H.); the Department of Pediatrics, Keiyu Hospital, Yokohama (N.S.), Hirotsu Clinic, Kawasaki (N.H.), the Department of Respiratory Medicine, Kurashiki Central Hospital, Kurashiki (T.I.), Sekino Hospital, Tokyo (H.S.), Tsuchiura Beryl Clinic, Tsuchiura (K.Y.), Shionogi, Osaka (K.K., T.S., M.A., K.T., T.U.), and the Research Division for Development of Anti-Infective Agents, Institute of Development, Aging..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeki","family":"Uehara","sequence":"additional","affiliation":[{"name":"From the Department of Medicine, University of Virginia School of Medicine, Charlottesville (F.G.H.); the Department of Pediatrics, Keiyu Hospital, Yokohama (N.S.), Hirotsu Clinic, Kawasaki (N.H.), the Department of Respiratory Medicine, Kurashiki Central Hospital, Kurashiki (T.I.), Sekino Hospital, Tokyo (H.S.), Tsuchiura Beryl Clinic, Tsuchiura (K.Y.), Shionogi, Osaka (K.K., T.S., M.A., K.T., T.U.), and the Research Division for Development of Anti-Infective Agents, Institute of Development, Aging..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Watanabe","sequence":"additional","affiliation":[{"name":"From the Department of Medicine, University of Virginia School of Medicine, Charlottesville (F.G.H.); the Department of Pediatrics, Keiyu Hospital, Yokohama (N.S.), Hirotsu Clinic, Kawasaki (N.H.), the Department of Respiratory Medicine, Kurashiki Central Hospital, Kurashiki (T.I.), Sekino Hospital, Tokyo (H.S.), Tsuchiura Beryl Clinic, Tsuchiura (K.Y.), Shionogi, Osaka (K.K., T.S., M.A., K.T., T.U.), and the Research Division for Development of Anti-Infective Agents, Institute of Development, Aging..."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"150","reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(11)70318-8"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.3390\/v7092850"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.2174\/09298673113209990208"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/med.21401"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature14008"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature14009"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature07720"},{"key":"e_1_3_4_9_2","unstructured":"The new drug application approval of \u201cAVIGAN\u00ae tablet 200mg\u201d in Japan for the anti-influenza virus drug. Press release of Toyama Chemical March 24 2014 (https:\/\/www.toyama-chemical.co.jp\/eng\/news\/news140324e.html)."},{"key":"e_1_3_4_10_2","unstructured":"Epstein C. Experience with favipiravir in phase 3 and implications for future studies. Presented at the 5th ISIRV-AVG Conference on Prevention and Treatment of RVIs: Antivirals Traditional Therapies and Host-Directed Interventions Shanghai China June 14\u201316 2017. abstract."},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm5007275"},{"key":"e_1_3_4_12_2","unstructured":"Finberg R Lanno R Anderson D et al. The Topaz trial: a phase 2B study of pimodivir (JNJ-63623872 or JNJ-872; formerly VX-787) as monotherapy or in combination with oseltamivir in the treatment of acute uncomplicated seasonal influenza. Presented at the 5th ISIRV-AVG Conference on Prevention and Treatment of RVIs: Antivirals Traditional Therapies and Host-Directed Interventions Shanghai China June 14\u201316 2017. abstract."},{"key":"e_1_3_4_13_2","unstructured":"O\u2019Neil B Ison M Hallouin-Bernard M et al. The Opal Trial: a placebo-controlled phase 2b trial studying pimodivir plus oseltamivir vs. placebo plus oseltamivir in adult and elderly hospitalized patients with influenza A infection. Presented as a late-breaking abstract at the 6th ESWI Conference Riga Latvia September 10\u201313 2017."},{"key":"e_1_3_4_14_2","unstructured":"Uehara T Shishido T Ishibashi T et al. S-033188 a small molecule inhibitor of Cap-dependent endonuclease of influenza A and B virus leads to rapid and profound viral load reduction. Presented at Options IX for the Control of Influenza Chicago August 24\u201328 2016. abstract."},{"key":"e_1_3_4_15_2","doi-asserted-by":"crossref","unstructured":"Kawasaki A Sato C Ishibashi T et al. A phase 1 study of safety tolerability and pharmacokinetics of oral single dose S-033188 a novel anti-influenza agent in healthy adult male participants. Presented at IDWeek New Orleans October 26\u201330 2016. abstract.","DOI":"10.1093\/ofid\/ofw172.1786"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkg007"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.283.8.1016"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02288-1"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00474-10"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1086\/520101"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1086\/600383"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/irv.12216"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofw023"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm1477"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)61125-3"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-11-319186"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit725"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.3851\/IMP1722"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f3039"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu632"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(16)30435-0"},{"key":"e_1_3_4_32_2","doi-asserted-by":"crossref","unstructured":"Kitano M Yamamoto A Noshi T et al. Synergistic antiviral activity of S-033188\/S-033447 a novel inhibitor of influenza virus cap-dependent endonuclease in combination with neuraminidase inhibitors in vitro. Presented at IDWeek San Diego CA October 4\u20138 2017. abstract.","DOI":"10.1093\/ofid\/ofx163.910"},{"key":"e_1_3_4_33_2","unstructured":"Shishido T Kurihara N Rokushima M et al. Genotypic and phenotypic monitoring of treatment-emergent resistance to S-033188 an influenza cap-dependent endonuclease inhibitor in a phase 2 randomized double-blind placebo-controlled study in otherwise healthy adults with seasonal influenza. Presented at the 5th ISIRV-AVG Conference on Prevention and Treatment of RVIs: Antivirals Traditional Therapies and Host-Directed Interventions Shanghai China June 4\u201316 2017. abstract."},{"key":"e_1_3_4_34_2","unstructured":"Noshi T Miki S Omoto S et al. Isolation and characterization of influenza A\/H1N1 virus resistant to S-033188\/S-033447 a novel inhibitor of influenza virus cap-dependent endonuclease. Presented at ASM Microbe New Orleans June 1\u20135 2017. abstract."},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00832-13"}],"container-title":["New England Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nejm.org\/doi\/pdf\/10.1056\/NEJMoa1716197","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T20:30:46Z","timestamp":1711485046000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.nejm.org\/doi\/10.1056\/NEJMoa1716197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,6]]},"references-count":34,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,9,6]]}},"alternative-id":["10.1056\/NEJMoa1716197"],"URL":"https:\/\/doi.org\/10.1056\/nejmoa1716197","relation":{},"ISSN":["0028-4793","1533-4406"],"issn-type":[{"value":"0028-4793","type":"print"},{"value":"1533-4406","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,6]]}}}